Clinical studies show that ABCC1 is upregulated in nonsmall cell lung cancer, breast cancer, ovarian cancer, renal cancer, and liver cancer, which is positively correlated with clinical–pathological stage and metastasis (Cao et al., 2017; Yamada et al., 2018). Here, ABCC1 is linked to breast cancer.